Clinical Trial Update: Methylnaltrexone vs Naloxegol in the Treatment of Opioid-Induced Constipation [Phase 4]

View source ↗

Summary

Phase 4 trial comparing methylnaltrexone with naloxegol for opioid-induced constipation has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Drugs mentioned

• Movantik (naloxegol) (naloxegol)
• Relistor (methylnaltrexone bromide) (methylnaltrexone bromide)

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Constipation Drug Induced | Phase 4 | Status: COMPLETED | Results posted: 2024-09-19